XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Stocks, currencies rise with focus on US data; Poland GDP beats estimates



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EMERGING MARKETS-Stocks, currencies rise with focus on US data; Poland GDP beats estimates</title></head><body>

Updated at 0850 GMT

Polish economic growth beats forecasts

Russian rouble continues to weaken

Thai court dismisses PM Srettha over cabinet appointment

Foreign investors buy net $7.91 bln of Asian bonds in July

By Lisa Pauline Mattackal

Aug 14 (Reuters) -Most emerging market currencies and stock indexes rose on Wednesday ahead of key U.S. inflation data, with hopes that easing price pressures would prompt bigger interest rate cuts from the Federal Reserve and relieve pressure on risk assets.

Data on Tuesday showed U.S. producer prices rose less than expected in July, lifting hopes that consumer price data, due later in the day, would also show moderating price pressures.

MSCI's index of emerging market stocks .MSCIEF and the broader EM currency index .MIEM00000CUS advanced 0.6% and 0.4%, respectively. The currency index is at its highest since April 2022.

"Most interesting for international markets is, of course, U.S. inflation," said Jens Magnusson, chief economist at SEB.

"The impression is that the Fed is becoming increasingly satisfied with wage and inflation developments ... we now believe that the Fed will cut interest rates by 100 basis points this year."

As worries increased about an economic slowdown in the U.S. affecting the global economy, markets have upped bets on the chance of a 50-basis-point rate cut from the Federal Reserve at its September meeting, now seeing a nearly 53% chance, according to CME's FedWatch.

Meanwhile, Poland's second-quarter gross domestic product (GDP) rose 3.2% on an annual basis, beating expectations, while inflation accelerated in July to 4.2% year-on-year, and from 2.6% in June.

However, the Polish zloty EURPLN= slipped 0.1% against the euro, as the common currency rose. FRX/

Russia's rouble RUB= continued its slide, falling to 91.7 per dollar, according to LSEG data, weighed by continuing escalation following Ukraine's biggest attack on the Russian territory since the start of the war.

However, the rouble picked off its lowest levels since October touched on Tuesday.

A stronger euro also weighed on central and eastern European currencies, with Hungary's forint EURHUF= retreating 0.2% after four straight sessions of gains.

Romania's leu EURRON= was flat versus the euro after a flash GDP estimate for the second quarter came in at 0.8%, well below forecasts.

Israeli stocks .TA125 gained 1% as trade resumed after a market holiday, despite heightened concerns over an escalating conflict in the region.

Stocks in Prague .PX, Warsaw .WIG20 and Istanbul .XU100 gained between 0.1% and 0.5%.

In Asia, the Thai baht THB=TH edged 0.1% higher against the dollar, while the country's main stock index .SETI fell nearly 1%. Thailand's Constitutional Court dismissed Prime Minister Srettha Thavisin for appointing to his cabinet a former lawyer who served jail time, raising the spectre of more political upheaval and a reset of the governing alliance.

Data showed overseas investors purchased a net $7.91 billion worth of bonds from emerging Asian markets including Indonesia, India and Malaysia.


HIGHLIGHTS:

** Chinese bonds rise after PBOC-backed media says risk warnings are working

** India's July wholesale prices rise 2.04% year-on-year

** Shunning home markets, South Korean retailers pile-up on US stocks



For TOP NEWS across emerging markets nTOPEMRG

For CENTRAL EUROPE market report, see CEE/

For TURKISH market report, see .IS

For RUSSIAN market report, see RU/RUB



For GRAPHIC on emerging market FX performance in 2024 http://tmsnrt.rs/2egbfVh

For GRAPHIC on MSCI emerging index performance in 2024 https://tmsnrt.rs/2OusNdX


Reporting by Lisa Mattackal in Bengaluru; Editing by Sherry Jacob-Phillips

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.